BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29019509)

  • 1. Hydroxylation of anilides by engineered cytochrome P450
    O'Hanlon JA; Ren X; Morris M; Wong LL; Robertson J
    Org Biomol Chem; 2017 Oct; 15(41):8780-8787. PubMed ID: 29019509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial alanine substitution enables rapid optimization of cytochrome P450BM3 for selective hydroxylation of large substrates.
    Lewis JC; Mantovani SM; Fu Y; Snow CD; Komor RS; Wong CH; Arnold FH
    Chembiochem; 2010 Dec; 11(18):2502-5. PubMed ID: 21108271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of perfluorocarboxylic acids to trick cytochrome P450BM3 into initiating the hydroxylation of gaseous alkanes.
    Kawakami N; Shoji O; Watanabe Y
    Angew Chem Int Ed Engl; 2011 May; 50(23):5315-8. PubMed ID: 21506212
    [No Abstract]   [Full Text] [Related]  

  • 4. P450
    Beyer N; Kulig JK; Bartsch A; Hayes MA; Janssen DB; Fraaije MW
    Appl Microbiol Biotechnol; 2017 Mar; 101(6):2319-2331. PubMed ID: 27900443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biocatalytic route to chiral acyloins: P450-catalyzed regio- and enantioselective α-hydroxylation of ketones.
    Agudo R; Roiban GD; Lonsdale R; Ilie A; Reetz MT
    J Org Chem; 2015 Jan; 80(2):950-6. PubMed ID: 25495724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laboratory-Scale Hydroxylation of Steroids by P450
    Hoebenreich S; Spinck M; Nett N
    Methods Mol Biol; 2017; 1645():239-257. PubMed ID: 28710633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Determinants of Substrate Affinity and Enzyme Activity of a Cytochrome P450
    Geronimo I; Denning CA; Heidary DK; Glazer EC; Payne CM
    Biophys J; 2018 Oct; 115(7):1251-1263. PubMed ID: 30224054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer Outer Membrane Protein Facilitates Uptake of Decoy Molecules into a Cytochrome P450BM3-Based Whole-Cell Biocatalyst.
    Karasawa M; Yonemura K; Stanfield JK; Suzuki K; Shoji O
    Angew Chem Int Ed Engl; 2022 Feb; 61(7):e202111612. PubMed ID: 34704327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hoodwinking Cytochrome P450BM3 into Hydroxylating Non-Native Substrates by Exploiting Its Substrate Misrecognition.
    Shoji O; Aiba Y; Watanabe Y
    Acc Chem Res; 2019 Apr; 52(4):925-934. PubMed ID: 30888147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the applicability of cytochrome P450s and other haemoproteins.
    Ariyasu S; Stanfield JK; Aiba Y; Shoji O
    Curr Opin Chem Biol; 2020 Dec; 59():155-163. PubMed ID: 32781431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Mutation and Substrate Binding on the Stability of Cytochrome P450BM3 Variants.
    Geronimo I; Denning CA; Rogers WE; Othman T; Huxford T; Heidary DK; Glazer EC; Payne CM
    Biochemistry; 2016 Jun; 55(25):3594-606. PubMed ID: 27267136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-specificity synthesis of novel monomers by remodeled alcohol hydroxylase.
    Zheng Y; Li L; Liu Q; Zhang H; Cao Y; Xian M; Liu H
    BMC Biotechnol; 2016 Aug; 16(1):61. PubMed ID: 27557638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 catalyzed oxidative hydroxylation of achiral organic compounds with simultaneous creation of two chirality centers in a single C-H activation step.
    Roiban GD; Agudo R; Reetz MT
    Angew Chem Int Ed Engl; 2014 Aug; 53(33):8659-63. PubMed ID: 24590553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Free energy calculations give insight into the stereoselective hydroxylation of α-ionones by engineered cytochrome P450 BM3 mutants.
    de Beer SB; Venkataraman H; Geerke DP; Oostenbrink C; Vermeulen NP
    J Chem Inf Model; 2012 Aug; 52(8):2139-48. PubMed ID: 22765880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly active single-mutation variant of P450BM3 (CYP102A1).
    Whitehouse CJ; Bell SG; Yang W; Yorke JA; Blanford CF; Strong AJ; Morse EJ; Bartlam M; Rao Z; Wong LL
    Chembiochem; 2009 Jul; 10(10):1654-6. PubMed ID: 19492389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Evolved Orthogonal Enzyme/Cofactor Pair.
    Reynolds EW; McHenry MW; Cannac F; Gober JG; Snow CD; Brustad EM
    J Am Chem Soc; 2016 Sep; 138(38):12451-8. PubMed ID: 27575374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of protein plasticity in computational rationalization studies on regioselectivity in testosterone hydroxylation by cytochrome P450 BM3 mutants.
    de Beer SB; van Bergen LA; Keijzer K; Rea V; Venkataraman H; Guerra CF; Bickelhaupt FM; Vermeulen NP; Commandeur JN; Geerke DP
    Curr Drug Metab; 2012 Feb; 13(2):155-66. PubMed ID: 22208530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxylation of non-substituted polycyclic aromatic hydrocarbons by cytochrome P450 BM3 engineered by directed evolution.
    Sideri A; Goyal A; Di Nardo G; Tsotsou GE; Gilardi G
    J Inorg Biochem; 2013 Mar; 120():1-7. PubMed ID: 23262457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Dynamics and QM/MM Calculations Predict the Substrate-Induced Gating of Cytochrome P450 BM3 and the Regio- and Stereoselectivity of Fatty Acid Hydroxylation.
    Dubey KD; Wang B; Shaik S
    J Am Chem Soc; 2016 Jan; 138(3):837-45. PubMed ID: 26716578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.